TGF-beta1/Smad-IN-1 (compound C9) is a potent inhibitor of TGF-beta1/Smad. It effectively suppresses the expression of fibrosis markers (alpha-SMA and COL1A1) induced by TGF-beta1 and exhibits antifibrotic properties. This compound holds potential for research in liver fibrosis.
Target-Kategorie:
TGF-beta/Smad
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
